Clinical Trial Uses Bat Saliva Enzyme for Stroke Treatment

Dec 30, 2008

(PhysOrg.com) -- Vampires aren't usually cast in the role of saviors, but stroke experts are hoping a blood thinner that mimics a chemical in vampire saliva will help save brain cells in stroke patients.

University of Wisconsin School of Medicine and Public Health is one of several centers worldwide currently enrolling patients in a large new clinical trial of desmoteplase, a drug based on an enzyme in vampire bat saliva.

The enzyme thins the blood of the bats' victims to prevent it from clotting as the bats feed. Its name comes from the scientific name for vampire bats, Desmodus Rotundus.

Early trials of the drug were encouraging that it may be able to extend the window of medical treatment up to nine hours after the onset of a stroke. The current gold standard for stroke treatment, alteplase, has been shown to be effective only up to four and one-half hours, and carries a risk of serious bleeding in a small percentage of patients.

Desmoteplase may be safer, and when used in combination with advanced brain-imaging techniques it may be effective hours later than the conventional clot-busting medicine.

After the initial promising findings, desmoteplase showed disappointing results in the second round of trials in which the entire group of patients taking it did only as well as those who got the placebo. But Dr. Matt Jensen, a UW Health stroke neurologist, says that a more careful look at the data suggest that there may be some patients who are better suited for the drug.

"We think that there is a group of patients who may benefit," he says. "With more advanced imaging, we hope to be able to identify people who are more likely to respond to the drug."

In an ischemic stroke (the most common kind), a blood clot blocks an artery to part of the brain, and over several hours without oxygenated blood, the brain cells begin to die. But Jensen explains that some patients have better circulation to the brain that allows enough blood to get around the blockage through other arteries.

This can allow the brain cells to survive longer until the blood clot is broken up, and good blood flow is restored. Physicians at UW Hospital will use advanced imaging techniques using MRI (magnetic resonance imaging) and CT (computed tomography) to find stroke patients who are better candidates for later treatments.

Jensen says that the physicians of the UW Health Comprehensive Stroke Program take calls from around the state from doctors looking to help patients who arrive too late for the standard treatments.

"As part of this trial, we will be able to treat certain people up to nine hours after the onset of stroke symptoms,'' he said. "With ground and helicopter transfers we can get people here quickly and potentially offer them a chance for this investigational treatment."

The DIAS-III trial, Desmoteplase In Acute Ischemic Stroke, plans to enroll 302 patients between December 2008 and December 2010.

Jensen stressed that it can be difficult for patients to recognize that they are having a stroke, and many people miss the chance for treatment by delaying getting medical evaluation in the nearest emergency department. The UW Health stroke site, www.uwhealth.org/stroke , has educational material including the following stroke warning signs, which should prompt an immediate 9-1-1 call:

• Sudden weakness or numbness of the face, arm or leg, especially on one side of the body
• Sudden confusion, trouble speaking or understanding
• Sudden trouble seeing in one or both eyes
• Sudden trouble walking, dizziness, loss of balance or coordination
• Sudden severe and unusual headache

Provided by University of Wisconsin

Explore further: Researcher develops, proves effectiveness of new drug for spinal muscular atrophy

add to favorites email to friend print save as pdf

Related Stories

Clot-dissolving bubbles to treat strokes?

Sep 25, 2013

(Medical Xpress)—Researchers are using computer simulations to investigate how ultrasound and tiny bubbles injected into the bloodstream might break up blood clots, limiting the damage caused by a stroke ...

Biologists decode turtle genome

Apr 23, 2013

A group of 50 researchers from around the globe, including biology professors Daniel Warren, Ph.D., from Saint Louis University and Leslie Buck, Ph.D., from the University of Toronto, have spent the last ...

Higgs Boson tops journal Science's top 10 of 2012

Dec 21, 2012

The discovery of the Higgs Boson, an invisible particle that explains the mystery of mass, leads a list of the top 10 scientific advances of 2012 released Thursday by the US journal Science.

Recommended for you

A novel therapy for sepsis?

6 hours ago

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

Cellular protein may be key to longevity

Sep 15, 2014

Researchers have found that levels of a regulatory protein called ATF4, and the corresponding levels of the molecules whose expression it controls, are elevated in the livers of mice exposed to multiple interventions ...

Gut bacteria tire out T cells

Sep 15, 2014

Leaky intestines may cripple bacteria-fighting immune cells in patients with a rare hereditary disease, according to a study by researchers in Lausanne, Switzerland. The study, published in The Journal of Experimental Me ...

User comments : 0